Clinical trial
TCR Sequencing and Transcriptional Profiling in Celiac Disease Patients Undergoing Gluten Challenge
NCT04614571 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TCR Sequencing and Transcriptional Profiling in Celiac Disease Patients Undergoing Gluten Challenge
- Lead sponsor
- Regeneron Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 2, 2020
- Completion date
- May 30, 2024
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.